Cancer Drug Pulled From Market Over Safety Concerns

(MedPage Today) — The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced.
The company also said it is discontinuing all active…